Home / Market Update / US Allows AstraZeneca to Resume Trials of Coronavirus Vaccine

US Allows AstraZeneca to Resume Trials of Coronavirus Vaccine

AstraZeneca said it has resumed trials in the United States of an experimental on Covid-19 vaccine after US regulatory approval.

On September 6, AstraZeneca suspended trials of its potential experimental coronavirus vaccine in the United States after a report that a participant in Britain’s trials had contracted a serious neurological disease believed to be transverse myelitis.

Check Also

European Stocks Dip Amid Trade Uncertainty; Oil Prices Rise on Trade Optimism

Corporate Woes Amid Tariff Concerns and EU-U.S. Trade Deal Talks European stocks faced a dip …